Aim Bulletin
Nanoco revenue jump driven by major US supply contract

Nano-materials developer Nanoco saw its shares dive on Wednesday despite forecasting a significant increase in revenue for the year ended 31 July.

Dairy cows, milk, butter, food
Frontier IP's The Vaccine Group gets grant for E.coli vaccine

University intellectual property commercialisation specialist Frontier IP announced on Wednesday that its portfolio company The Vaccine Group (TVG) has been awarded a £50,000 grant from the global Bacterial Vaccine Network, to support development of a vaccine to combat one of the main causes of bovine mastitis, E. coli.

Tern's FundamentalVR launches surgery simulator in US market

Internet of things investment company Tern noted an announcement from its portfolio company FundamentalVR on Wednesday, that it has launched ‘Fundamental Surgery’, a “first-of-its-kind” software-as-a-service platform, in the US.

DeepMatter meets 2018 goal for 'DigitalGlassware' pioneer numbers

Chemistry digitising company DeepMatter has now entered into agreements with a total of five organisations for its ‘DigitalGlassware’ pioneer programme, which represents the minimum that it planned to initiate during 2018, it announced on Wednesday.

ep smartphonelectorhuella
NetScientific's Wanda launches 'CareLink' digital health product

Transatlantic healthcare IP commercialisation group NetScientific announced on Wednesday that portfolio company Wanda, which it said uses machine learning to help healthcare providers better manage the risk and care of patients, has launched its new digital health application ‘Wanda CareLink’.

Versarien's China expansion boosted by further govt employee secondment

Advanced materials engineering group Versarien on Wednesday saw a second Department for International Trade (DIT) secondee join its ranks.

pharma, biotech, drugs, lab, gsk, glaxo, trials,  clinical
Akers Biosciences profits hit over antigen difficulties

Akers Biosciences' losses burgeoned as second-quarter revenues were cut in half after softer sales of its flagship Heparin rapid assay products had offset a stronger showing in its breathalyser unit.

ep recursopharmamar
Feedback's TexRAD reaches India after first GE Healthcare order

Medical imaging technology firm Feedback’s operating company Feedback Medical on Wednesday received its first order via GE Healthcare for its patented image texture analysis technology TexRAD.

drilling oil onshore
Savannah Petroleum continues 100% success record with Niger discovery

British independent oil and gas company Savannah Petroleum on Wednesday made a new oil discovery through its Eridal-1 exploration well in the Agadem Rift Basin, South East Niger.

mining polymetal
Cadence lauds acceleration of Auroch Minerals' drilling programme

Cadence Minerals on Wednesday reported that investee company Auroch Minerals accelerated its drilling programme with the start of works at its Bonaventura base metals project in South Australia.

ep software ordenador pc
Stilo tumbles as profit drop following loss of key customer

AIM-listed Stilo International reported a fall in first-half profits after the software group was unable to retain a key customer.

cbargentina1cris1 short1
ECR Minerals reports new enthusiasm for Argentina

Precious metals exploration and development company ECR Minerals updated the market on Wednesday, following the visit by the company to Argentina to discuss the status and plans in respect of its existing interests, and also to consider potential new opportunities in Argentina that may complement existing interests.

ep electricidad energia cables torres electricas corriente 20171017172202
Kibo signs MoU to buy 60pc of Mast Energy Developments

Africa focused energy company Kibo Energy has signed a memorandum of understanding (MoU) for the acquisition of a 60% equity interest in Mast Energy Developments (MED) - a private UK-registered company targeting the development and operation of flexible power plants to service the reserve power generation market - it announced on Wednesday.

ep cascovr independiente oculus go
EVR signs deal to bring more Ally Pally gigs to VR

Virtual reality music content producer EVR Holdings announced an exclusive multi-year partnership with Alexandra Palace Trading on Wednesday.

Keras Resources pressing ahead with Nayega sampling programme

Mineral resource company Keras Resources announced a number of appointments to advance the 10,000 tonne bulk sampling metallurgical testwork programme at the Nayega Manganese Project in northern Togo on Wednesday, which it said hosted a current JORC Code mineral resource of 13. 97Mt at 12. 4% manganese.

currencies euro dollar pound money cash sterling
Vast Resources takes indirect stake in Romania's Blueberry Project

Mining company Vast Resources announced the acquisition of an indirect 29. 41% interest in the Blueberry Project, which hosts highly prospective polymetallic mineralisation and is located in the ‘Golden Quadrilateral’ of Western Romania, on Wednesday.

ep arenal sound 20180625185003
Arena Events looks to raise £20m to fund acquisitions

Arena Events Group is looking to raise as much as £20m by way of a placing of up to 33. 33m new shares at a price of 60p as it agreed the acquisitions of Stuart Rental and TGP to boost its overseas operations.

14 Aug
mining truck, commodities, minerals, iron ore
KEFI Minerals prepares for development at Ethiopian asset

AIM-listed copper ores company KEFI Minerals has appointed itself a new head of project implementation as the company ramps-up preparations for the development of its Tulu Kapi gold project in Ethiopia.

14 Aug
FDA accepts new drug application for Motif Bio's iclaprim

Clinical-stage biopharmaceutical company Motif Bio announced on Tuesday that the US Food and Drug Administration has accepted for filing its new drug application (NDA) for iclaprim - a targeted, gram-positive investigational antibiotic, for the treatment of acute bacterial skin and skin structure infections (ABSSSI).

14 Aug
ep pangaea oncology
SalvaRx offloads immuno-oncology assets to Portage Biotech

AIM-listed biotechnology company SalvaRx has entered into a conditional sale agreement that would see the Cambridgeshire-based firm offload its immuno-oncology assets to Portage Biotech.